Heart Attack Blood Oxygen Therapy Trial

NARecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 25, 2024

Primary Completion Date

November 1, 2028

Study Completion Date

November 1, 2038

Conditions
Myocardial InfarctRemodeling, Left Ventricle
Interventions
OTHER

Supersaturated oxygen

"Supersaturated O2 (SSO2) therapy immediately following primary percutaneous coronary intervention (PCI) using radial artery access in the cardiac catheter laboratory.~https://www.zoll.com/products/supersaturated-oxygen-therapy"

OTHER

Sham (No Treatment)

Control (sham) procedure involving wrist manipulation in addition to standard care.

Trial Locations (1)

G81 4DY

RECRUITING

Golden Jubilee National Hospital, Clydebank

All Listed Sponsors
collaborator

British Heart Foundation

OTHER

collaborator

Zoll Medical Corporation

INDUSTRY

collaborator

Robertson Centre for Biostatistics - University of Glasgow

UNKNOWN

lead

NHS National Waiting Times Centre Board

OTHER